Position in ORGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$180
+$38 QoQ
Shares Held
76
+130.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $34,968,542 across 41 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
466,714 | $7,481,424 | |
| 2 | HLN |
Haleon plc
|
650,820 | $6,072,149 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
155,892 | $5,281,619 | |
| 4 | ZTS |
Zoetis Inc.
|
54,002 | $3,880,582 | |
| 5 | VTRS |
Viatris Inc
|
220,066 | $3,494,647 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
189,028 | $2,739,015 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
11,941 | $1,324,734 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
29,837 | $1,034,448 |
All Filings in ORGO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $180 | 76 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $142 | 33 | Shares | Defined | 2025-05-08 | |
| 2023-03-31 | $213 | 100 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $72 | 27 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,318 | 407 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,236 | 556 | Shares | Defined | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||